Co-Diagnostics (NASDAQ: CODX) reported Q3 EPS of ($0.04), $0.10 worse than the analyst estimate of $0.06. Revenue for the quarter came in at $5.1 million versus the consensus estimate of $15.33 million.

For earnings history and earnings-related data on Co-Diagnostics (CODX) click here.